-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Gilead Sciences, Raises Price Target to $145

Benzinga·10/31/2025 21:12:51
Listen to the news
Wells Fargo analyst Mohit Bansal maintains Gilead Sciences (NASDAQ:GILD) with a Overweight and raises the price target from $140 to $145.